Cluster Randomized Trial Designs in Cancer Care Delivery Research - Faculty

Faculty

Course Co-Directors:

Sandra A. Mitchell, PhD, CRNP, FAAN
sandra.mitchell@nih.gov

Sandra A. Mitchell, PhD, CRNP, FAAN is Senior Scientist and Program Director in the Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences at the National Cancer Institute. She directs a portfolio of research focused in several areas, including the development and testing of interventions to address symptom burden and functional impairment, and to improve self-management during and following cancer treatment. She serves as a Science Officer for the Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium. Additional areas of research interest include implementation science and novel trial designs for cancer care delivery research.

Wynne E. Norton, PhD
wynne.norton@nih.gov

Wynne E. Norton, Ph.D. is a Program Director in Implementation Science in the Division of Cancer Control and Population Sciences at the National Cancer Institute. She also holds a secondary appointment in the Healthcare Delivery Research Program. Dr. Norton’s research interests include de-implementation of ineffective interventions, evidence-based cancer care delivery, and pragmatic trials of implementation strategies. Dr. Norton serves as a scientific collaborator on three NCI Cancer MoonshotSM Initiatives: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science Consortium (ACCSIS), Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium, and the Implementation Science Centers in Cancer Control (ISC3).

Course Faculty:

Karla Hemming, PhD
k.Hemming@bham.ac.uk

Karla Hemming, PhD is a Professor of Biostatistics at the Institute of Applied Health Research, University of Birmingham, UK. Dr. Hemming’s research interests include how to design cluster and stepped-wedge trials so as to maximize their statistical efficiency and minimize their risk of bias; how to model time and treatment effect heterogeneity in longitudinal cluster trials; and the ethical issues surrounding these pragmatic trial designs, such as ethical oversight and consent. She has recently led the development of the CONSORT extension for the stepped-wedge cluster randomized trial.

Monica Taljaard, PhD
mtaljaard@ohri.ca

Monica Taljaard, PhD is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute (OHRI) and Professor in the School of Epidemiology and Public Health at the University of Ottawa. Having immigrated from South Africa, she received her PhD degree in Epidemiology and Biostatistics at Western University in London, Ontario, Canada, in 2006. Her research interests include the design, analysis and ethics of pragmatic and cluster randomized trials. As a methodologist with the Ottawa Methods Centre, she works with clinicians and researchers from a variety of backgrounds in the design and analysis of cluster randomized trials, standard clinical trials, and observational studies. She is Deputy Editor of Clinical Trials: Journal of the Society for Clinical Trials.